SCHEMBL2761875

SCHEMBL2761875

COC(=O)c1c(O)c2cc(-c3ccc(Oc4ccccc4)cc3)ccc2oc1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 1/20 0.46
PTGS2 P35354 2/20 0.45
KDM4E B2RXH2 4/20 0.44
GAA P10253 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
ALOX15 P16050 2/20 0.44
POLB P06746 2/20 0.44
MAOB P27338 2/20 0.44
CA12 O43570 2/20 0.43
CA9 Q16790 2/20 0.43
RCE1 Q9Y256 1/20 0.43
RECQL P46063 1/20 0.43
ACHE P22303 1/20 0.43
ERN1 O75460 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2761594 0.91 NQO1 (0.47) ALDH1A1L3MBTL1ATMKDM4EGAA
SCHEMBL2761865 0.88 MAOB (0.56) ALDH1A1L3MBTL1ATMKDM4EGAA
SCHEMBL2762426 0.86 ANO1 (0.50) ALDH1A1L3MBTL1KDM4EGAAMAPT
SCHEMBL2761574 0.83 HIF1A (0.53)
SCHEMBL2761637 0.81 MAOB (0.44) ALDH1A1MAOBCA12CA9RCE1
SCHEMBL6720349 0.79 POLB (0.55) ALDH1A1L3MBTL1PTGS2KDM4EGAA
SCHEMBL2762010 0.79 L3MBTL1 (0.58) ALDH1A1L3MBTL1KDM4EMAPTMAOB
SCHEMBL2762161 0.78 ALDH1A1 (0.52) ALDH1A1ATMKDM4EGAAMAPT
SCHEMBL2761745 0.77 ALDH1A1 (0.72) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL2761878 0.77 NQO1 (0.49) ALDH1A1L3MBTL1KDM4EGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324405-B2 Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors FIBROGEN, INC. (US) 2012-12-04 US disclosed
US-20100331400-A1 CHROMENE DERIVATIVES AND USE THEREOF AS HIF HYDROXYLASE ACTIVITY INHIBITORS FIBROGEN, INC. 2010-12-30 US disclosed
WO-2009100250-A1 CHROMENE DERIVATIVES AND USE THEREOF AS HIF HYDROXYLASE ACTIVITY INHIBITORS FIBROGEN, INC. (US) 2009-08-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331400-A1 CHROMENE DERIVATIVES AND USE THEREOF AS HIF HYDROXYLASE ACTIVITY INHIBITORS HIF1AN, HIF1A, EGLN2 ALDH1A1 202/4885L3MBTL1 3898/4885ATM 1966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.